Miguel Angel Martinez

Dr. Miguel Angel Martinez

IrsiCaixa - Institute for AIDS Research; Germans Trias i Pujol Research Institute, IGTP, Badalona, Spain
orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2020 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
Miguel Angel MartinezMiguel Angel Martinez
Miguel Angel Martinez
Currently, the expansion of the novel human respiratory coronavirus (known as SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], COVID-2019 [coronavirus disease 2019], or 2019-nCoV [2019 novel coronavirus]) has stressed the need for therapeutic alternatives to alleviate and stop this new epidemic. The previous epidemics of infections by high-morbidity human coronaviruses, such as SARS-CoV in 2003 and the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, prompted the characterization of compounds that could be potentially active against the currently emerging novel coronavirus, SARS-CoV-2.

1 December 2002 in AIDS
Verified
Journal Article
Closed access
Miguel Angel MartinezMiguel Angel Martinez
Miguel Angel Martinez
AGArantxa Gutiérrez
Arantxa Gutiérrez
MAMercedes Armand-Ugón
Mercedes Armand-Ugón
JBJulià Blanco
Julià Blanco
MPMariona Parera
Mariona Parera
JEJose Este
Jose Este
Duplexes of 21 base pair RNA, known as short-interfering RNA (siRNA), have been shown to inhibit gene expression by a sequence-specific RNA degradation mechanism termed RNA interference (RNAi). The objective of our study was to evaluate the effect of chemokine receptor gene suppression by RNAi on the entry and replication of HIV-1. A flow cytometry and microscopy evaluation of HIV co-receptor expression of cells transfected with siRNA. An evaluation of the effect of siRNA on HIV entry and replication by intracellular p24 antigen detection, and virus production by infected cells, respectively. siRNA that target CXCR4 and CCR5 could effectively impede cell surface protein expression and their consequent function as HIV co-receptors. The inhibitory effect of RNAi directed to CXCR4 was detected 48 h after transfection of CXCR4+ U87-CD4+ cells. The expression of CXCR4 and CCR5 was blocked in 63 and 48% of positive cells by the corresponding siRNA. However, siRNA directed to CXCR4 or CCR5 did not have an effect on CD4 cells or green fluorescence protein expression. siRNA directed to CXCR4 did not suppress CCR5 expression or vice versa. The suppression of HIV-1 co-receptor expression effectively blocked the acute infection of CXCR4+ or CCR5+ U87-CD4+ cells by X4 (NL4-3) or R5 (BaL) HIV-1 strains. Inhibition of virus replication occurred regardless of the multiplicity of infection employed. Our results demonstrate that RNAi may be used to block HIV entry and replication through the blockade of cellular gene expression. Gene silencing by siRNA may become a valid alternative for HIV intervention.

1 March 1990 in Journal of General Virology
Verified
Journal Article
Closed access
MMMauricio G. Mateu
Mauricio G. Mateu
Miguel Angel MartinezMiguel Angel Martinez
Miguel Angel Martinez
LCLorenzo Capucci
Lorenzo Capucci
DAD. Andreu
D. Andreu
Ernest GiraltErnest Giralt
Ernest Giralt
EDEsteban Domingo
Esteban Domingo
Neutralizing monoclonal antibodies (nMAbs) elicited against foot-and-mouth disease virus (FMDV) of serotype C were assayed with field isolates and variant FMDVs using several immunoassays. Of a total of 36 nMAbs tested, 23 recognized capsid protein VP1 and distinguished at least 13 virion conformation-independent epitopes involved in neutralization of FMDV C. Eleven epitopes of FMDV C-S8c1 have been located in segments 138–156 or 192–209 of VP1 by quantifying the reactivity of nMAbs with synthetic peptides and with nMAb-resistant mutants of FMDV C-S8c1 carrying defined amino acid substitutions. The main antigenic site of FMDV C-S8c1 (VP1 residues 138 to 150) consists of multiple (at least 10), distinguishable, overlapping epitopes. Some amino acid replacements abolished one of the epitopes, whereas other replacements affected several epitopes in this region. The conservative substitution His(146) → Arg, found in many nMAb-resistant mutants analysed, abolished the reactivity of the virus with all nMAbs that recognized epitopes in the main antigenic site of FMDV C-S8c1. This indicates that a minimum genetic change can result in a highly amplified phenotypic effect, as regards the antigenicity of FMDV.

1 September 2014 in Journal of Clinical Virology
Verified
Journal Article
Closed access
Miguel Quiñones-MateuMiguel Quiñones-Mateu
Miguel Quiñones-Mateu
SASantiago Avila
Santiago Avila
GRGustavo Reyes-Teran
Gustavo Reyes-Teran
Miguel Angel MartinezMiguel Angel Martinez
Miguel Angel Martinez


24 June 1997 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
Miguel Angel MartinezMiguel Angel Martinez
Miguel Angel Martinez
Núria VerdaguerNúria Verdaguer
Núria Verdaguer
MMMauricio G. Mateu
Mauricio G. Mateu
EDEsteban Domingo
Esteban Domingo
Aphthoviruses use a conserved Arg-Gly-Asp triplet for attachment to host cells and this motif is believed to be essential for virus viability. Here we report that this triplet—which is also a widespread motif involved in cell-to-cell adhesion—can become dispensable upon short-term evolution of the virus harboring it. Foot-and-mouth disease virus (FMDV), which was multiply passaged in cell culture, showed an altered repertoire of antigenic variants resistant to a neutralizing monoclonal antibody. The altered repertoire includes variants with substitutions at the Arg-Gly-Asp motif. Mutants lacking this sequence replicated normally in cell culture and were indistinguishable from the parental virus. Studies with individual FMDV clones indicate that amino acid replacements on the capsid surface located around the loop harboring the Arg-Gly-Asp triplet may mediate in the dispensability of this motif. The results show that FMDV quasispecies evolving in a constant biological environment have the capability of rendering totally dispensable a receptor recognition motif previously invariant, and to ensure an alternative pathway for normal viral replication. Thus, variability of highly conserved motifs, even those that viruses have adapted from functional cellular motifs, can contribute to phenotypic flexibility of RNA viruses in nature.